Jolt-Ca Stablemates Trial
Research type
Research Study
Full title
JoLT-Ca A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC), The STABLE-MATES Trial
IRAS ID
281607
Contact name
Joel Dunning
Contact email
Sponsor organisation
South Tees Hospital NHS Foundation Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
3 years, 0 months, 0 days
Research summary
This is a phase III randomized trial comparing sublobar resection to SAbR radiation in high risk stage I lung cancer patients. The purpose of the study is to confirm which procedure is more effective and safer. In order to confirm this patients will be 1:1 randomised to one of these procedures and then subsequently monitored to assess their health outcomes (specifically survival data and side effects) which will include visits 4 weeks after treatment then every 3 months for 2 years, then every 6 months for 3 more years. If patients decline to be randomised to one of the treatments we will still ask if they are happy for their data to be collected to aid the study analysis.
REC name
East of Scotland Research Ethics Service REC 2
REC reference
21/ES/0083
Date of REC Opinion
20 Oct 2021
REC opinion
Further Information Favourable Opinion